Kyle Hadden

Recognized as a leader in the field of medicinal chemistry, Kyle Hadden serves as the Director of Research and Graduate Programs and a Professor at the University of Connecticut School of Pharmacy. With a robust educational foundation, he earned his B.S. in Chemistry from Wofford College, followed by a Ph.D. in Medicinal Chemistry from the Medical University of South Carolina. Further honing his expertise, he completed postdoctoral training in Medicinal Chemistry at the University of Kansas. Professor Hadden's research is at the forefront of developing innovative therapeutic strategies. His work primarily revolves around the organic synthesis of small molecule hedgehog pathway modulators, a crucial area in the treatment of various cancers and neurodegenerative disorders. By employing advanced cell-based assays, he meticulously evaluates the efficacy of these compounds, aiming to translate his findings into viable clinical applications. In addition to his research on hedgehog pathway modulators, Professor Hadden is deeply involved in high-throughput screening techniques. This approach allows for the rapid identification of potential therapeutic agents, significantly accelerating the drug discovery process. His contributions to the field are not only advancing scientific understanding but also paving the way for new treatments that could improve patient outcomes. Beyond his research endeavors, Professor Hadden is dedicated to mentoring the next generation of scientists. He actively engages with graduate students, guiding them through the complexities of medicinal chemistry and fostering an environment of innovation and collaboration. His commitment to education and research excellence continues to inspire both his peers and students alike.